http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114681457-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114681457-B
titleOfInvention Buprenorphine transdermal solution and preparation method and application thereof
abstract The present invention provides a buprenorphine transdermal solution and a preparation method and application thereof. The solution uses buprenorphine as an active ingredient, and contains phospholipid-polyethylene glycol, a transdermal enhancer and a non-polar solvent. Addresses the problems of frequent buprenorphine administration and skin irritation in mammals, and provides a new regimen for sustained pain control. The buprenorphine transdermal solution of the invention has the effects of rapid absorption, slow release, high safety and long-acting analgesia, and can be used for postoperative analgesia in mammals.
priorityDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019064026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2002299-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6004969-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9834808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421183892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22074736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15061530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86278269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452768203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411307510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175

Total number of triples: 46.